Patients with Merkel Cell Carcinoma who underwent a procedure called sentinel lymph node biopsy (SNLB) had a lower risk of cancer recurrence after two years, according to a study by researchers from Fox Chase Cancer Center. When the biopsy's results were used to guide subsequent tests and treatment, these patients had longer survival rates than patients who had not undergone the procedure. "Sentinel lymph node biopsy, or SNLB, can be used to recommend which way to proceed with a patient's treatment," says Aruna Turaka, M.D...
More...
More...